John Overdeck’s Jupiter Neurosciences JUNS Stock Holding History

John Overdeck’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-290	Closed	-$13.3K	–	3638
2025 Q1	$13.3K	Buy	+290	New	+$47.1K	﹤0.01%	3125

Other funds holding JUNS

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

John Overdeck's JUNS Position: Q2 2025 in Review

John Overdeck sold out of Jupiter Neurosciences (JUNS) in Q2 2025, closing a stake of 290 shares — an estimated $13.3K sold.

John Overdeck first reported a position in JUNS in Q1 2025 and held it in 1 quarter. The position peaked at $13.3K in Q1 2025. 2 funds tracked by Wall St. Rank hold JUNS as of Q2 2025.

John Overdeck reported no remaining Jupiter Neurosciences position as of Q2 2025 after selling out during the quarter.
John Overdeck sold 290 Jupiter Neurosciences shares in Q2 2025, an estimated $13.3K.
John Overdeck first reported a position in Jupiter Neurosciences in Q1 2025 and held it in 1 quarter.
John Overdeck's Jupiter Neurosciences position peaked at $13.3K in Q1 2025.
2 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.